Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Simon, A.
Right arrow Articles by Laufer, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, A.
Right arrow Articles by Laufer, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 13, No. 10, 2712-2717, October 1998
© 1998 European Society of Human Reproduction and Embryology

Transfer of frozen–thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study

Alex Simon, Arye Hurwitz, Bat-Sheva Zentner, Yuval Bdolah and Neri Laufer

Department of Obstetrics and Gynecology, Hadassah University Hospital, Mount Scopus, P.O. Box 24035, Jerusalem 91240, Jerusalem, Israel

Correspondence: To whom correspondence should be addressed

Transfer of frozen–thawed embryos is usually carried out in a natural cycle or in a programmed cycle in which the endometrium is exogenously stimulated following down-regulation of the hypophysis. To analyse the possibility that the programmed cycle for embryo transfer can still be hormonally manipulated without the use of gonadotrophin-releasing hormone agonist (GnRHa) we have conducted a prospective randomized study that compared the outcome of frozen–thawed embryo transfer cycles using micronized 17ß-Oestradiol and micronized progesterone preparations with and without the concomitant use of GnRHa. One hundred and six patients were randomly divided into two groups. In group A (53 patients) 4 mg/day of micronized 17ß-oestradiol was initiated following down-regulation of hypophysis. In group B (53 patients) oestrogen stimulation started on day 1 of the cycle without prior pituitary down-regulation using a dose of 6 mg/day for 7 days. In both groups, micronized progesterone in a dose of 900 mg/day was administered vaginally after at least 12 days of oestrogen stimulation. Embryo transfer embryo transfer took place 48-72 h thereafter according to the cryopreserved embryonic stage. Overall, none of the patients had any follicular development and only one cycle in group B had to be cancelled because of premature progesterone secretion. The two groups did not differ in age (31 ± 5.6 and 31 ± 5.0 years), number of embryos transferred per patient (3.4 ± 1.2 and 3.3 ± 1.0), and day of progesterone initiation (15 ± 2.2 and 15 ± 1.9 for groups A and B respectively). The endometrial thickness on the day of progesterone initiation was comparable in both groups (11 ± 1.6 and 10 ± 1.6 mm for groups A and B respectively). Similarly, the pregnancy rate per embryo transfer and implantation rate in group A (26.4% and 9.5%) were comparable to those of group B (21.1% and 9%). These results indicate that programmed cycles can be successfully applied by administering a high dose of micronized 17ß-oestradiol starting on day 1 of the cycle. Compared to GnRHa programmed cycles, this approach is simpler, more convenient for both the patient and medical staff, and results in a similar success rate at a lower cost.

Key words: artificial cycle/cryopreservation/embryo/endometrial preparation/GnRH agonist/thawing


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
G. Griesinger, M. Weig, A. Schroer, K. Diedrich, and E.M. Kolibianakis
Mid-cycle serum levels of endogenous LH are not associated with the likelihood of pregnancy in artificial frozen-thawed embryo transfer cycles without pituitary suppression
Hum. Reprod., October 1, 2007; 22(10): 2589 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Nawroth and M. Ludwig
What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols?
Hum. Reprod., May 1, 2005; 20(5): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. El-Toukhy, A. Taylor, Y. Khalaf, K. Al-Darazi, P. Rowell, P. Seed, and P. Braude
Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study
Hum. Reprod., April 1, 2004; 19(4): 874 - 879.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Lightman, S. Kol, and J. Itskovitz-Eldor
A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles
Hum. Reprod., October 1, 1999; 14(10): 2596 - 2599.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.